141 related articles for article (PubMed ID: 35073298)
21. Taxane-Induced Peripheral Neuropathy: Objective and Subjective Comparison Between Paclitaxel and Docetaxel in Patients With Breast Cancer.
Chan YN; Jheng YW; Wang PJ; Chen CY; Lin MW; Wang YJ
Clin J Oncol Nurs; 2019 Oct; 23(5):494-501. PubMed ID: 31538967
[TBL] [Abstract][Full Text] [Related]
22. Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy.
Bandla A; Tan S; Kumarakulasinghe NB; Huang Y; Ang S; Magarajah G; Hairom Z; Lim JSJ; Wong A; Chan G; Ngoi N; Ang E; Lee YM; Chan A; Lee SC; Thakor N; Wilder-Smith E; Sundar R
Support Care Cancer; 2020 Aug; 28(8):3691-3699. PubMed ID: 31811482
[TBL] [Abstract][Full Text] [Related]
23. Compression therapy using surgical gloves does not prevent paclitaxel-induced peripheral neuropathy: results from a double-blind phase 2 trial.
Kotani H; Terada M; Mori M; Horisawa N; Sugino K; Kataoka A; Adachi Y; Gondou N; Yoshimura A; Hattori M; Sawaki M; Takahata C; Kobara M; Iwata H
BMC Cancer; 2021 May; 21(1):548. PubMed ID: 33985457
[TBL] [Abstract][Full Text] [Related]
24. Time-to-Event Analysis of Paclitaxel-Associated Peripheral Neuropathy in Advanced Non-Small-Cell Lung Cancer Highlighting Key Influential Treatment/Patient Factors.
Ojara FW; Henrich A; Frances N; Huisinga W; Hartung N; Joerger M; Kloft C
J Pharmacol Exp Ther; 2020 Dec; 375(3):430-438. PubMed ID: 33008871
[TBL] [Abstract][Full Text] [Related]
25. Effects of Cryotherapy on Objective and Subjective Symptoms of Paclitaxel-Induced Neuropathy: Prospective Self-Controlled Trial.
Hanai A; Ishiguro H; Sozu T; Tsuda M; Yano I; Nakagawa T; Imai S; Hamabe Y; Toi M; Arai H; Tsuboyama T
J Natl Cancer Inst; 2018 Feb; 110(2):141-148. PubMed ID: 29924336
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
[TBL] [Abstract][Full Text] [Related]
27. Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships.
Hertz DL
Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):227-239. PubMed ID: 33401943
[No Abstract] [Full Text] [Related]
28. [Possibility of Prolonging Treatment by Preventing Paclitaxel-Induced Peripheral Neuropathy Using Compression Therapy].
Tsuyuki S; Hamada-Nishimoto M; Kang Y; Katayama T
Gan To Kagaku Ryoho; 2022 Nov; 49(11):1241-1245. PubMed ID: 36412028
[TBL] [Abstract][Full Text] [Related]
29. [Effects of cryotherapy on chemotherapy-induced peripheral neuropathy: self-controlled clinical trial].
Hanai A
Nihon Yakurigaku Zasshi; 2019; 154(5):245-248. PubMed ID: 31735752
[TBL] [Abstract][Full Text] [Related]
30. Persistence of docetaxel-induced neuropathy and impact on quality of life among breast cancer survivors.
Eckhoff L; Knoop A; Jensen MB; Ewertz M
Eur J Cancer; 2015 Feb; 51(3):292-300. PubMed ID: 25541155
[TBL] [Abstract][Full Text] [Related]
31. Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.
Sun Y; Kim JH; Vangipuram K; Hayes DF; Smith EML; Yeomans L; Henry NL; Stringer KA; Hertz DL
Breast Cancer Res Treat; 2018 Oct; 171(3):657-666. PubMed ID: 29946863
[TBL] [Abstract][Full Text] [Related]
32. [Clinical features of paclitaxel-induced peripheral neuropathy and role of Gosya-jinki-gan].
Yamamoto T; Murai T; Ueda M; Katsuura M; Oishi M; Miwa Y; Okamoto Y; Uejima E; Taguchi T; Noguchi S; Kurokawa N
Gan To Kagaku Ryoho; 2009 Jan; 36(1):89-92. PubMed ID: 19151569
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and predictors of peripheral neuropathy after breast cancer treatment.
Kamgar M; Greenwald MK; Assad H; Hastert TA; McLaughlin EM; Reding KW; Paskett ED; Bea JW; Shadyab AH; Neuhouser ML; Nassir R; Crane TE; Sreeram K; Simon MS
Cancer Med; 2021 Oct; 10(19):6666-6676. PubMed ID: 34390205
[TBL] [Abstract][Full Text] [Related]
34. Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel.
Iñiguez C; Larrodé P; Mayordomo JI; González P; Adelantado S; Yubero A; Trés A; Morales F
Neurology; 1998 Sep; 51(3):868-70. PubMed ID: 9748043
[TBL] [Abstract][Full Text] [Related]
35. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study.
Leal AD; Qin R; Atherton PJ; Haluska P; Behrens RJ; Tiber CH; Watanaboonyakhet P; Weiss M; Adams PT; Dockter TJ; Loprinzi CL;
Cancer; 2014 Jun; 120(12):1890-7. PubMed ID: 24619793
[TBL] [Abstract][Full Text] [Related]
36. A Randomized Assessor-Blinded Wait-List-Controlled Trial to Assess the Effectiveness of Acupuncture in the Management of Chemotherapy-Induced Peripheral Neuropathy.
Molassiotis A; Suen LKP; Cheng HL; Mok TSK; Lee SCY; Wang CH; Lee P; Leung H; Chan V; Lau TKH; Yeo W
Integr Cancer Ther; 2019; 18():1534735419836501. PubMed ID: 30905173
[TBL] [Abstract][Full Text] [Related]
37. Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors.
Kober KM; Olshen A; Conley YP; Schumacher M; Topp K; Smoot B; Mazor M; Chesney M; Hammer M; Paul SM; Levine JD; Miaskowski C
Mol Pain; 2018; 14():1744806918816462. PubMed ID: 30426838
[TBL] [Abstract][Full Text] [Related]
38. An Evaluation of the Efficacy of Compression Therapy Using Sleeves and Stockings to Prevent Docetaxel-induced Peripheral Neuropathy in Breast Cancer Patients.
Yamanouchi K; Kuba S; Matsumoto M; Yano H; Morita M; Sakimura C; Otsubo R; Hidaka M; Nagayasu T; Eguchi S
Acta Med Okayama; 2022 Dec; 76(6):689-694. PubMed ID: 36549771
[TBL] [Abstract][Full Text] [Related]
39. The trend of chemotherapy-induced peripheral neurotoxicity in ovarian cancer survivors and its impacts on daily life during and one year after treatment.
Jing Y; Lv HY; Feng SW
Eur J Gynaecol Oncol; 2016; 37(5):696-699. PubMed ID: 29787013
[TBL] [Abstract][Full Text] [Related]
40. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing.
Forsyth PA; Balmaceda C; Peterson K; Seidman AD; Brasher P; DeAngelis LM
J Neurooncol; 1997 Oct; 35(1):47-53. PubMed ID: 9266440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
